Our Team

Toxistrategy

Partner

Dessi is a board-certified toxicologist providing strategic nonclinical safety consulting to biotech and pharma companies developing cutting-edge therapeutics. She is a Diplomate of the American Board of Toxicology and holds an MS in Pharmacology and Toxicology from Michigan State University. 

Dessi brings 15 years of experience spanning nonclinical safety strategy, in vivo toxicology, and regulatory submission leadership. Her expertise covers a wide range of modalities—including small molecules, biologics, ADCs, oligonucleotides, radiopharmaceuticals, gene and cell therapies—and therapeutic areas such as oncology, immunology, CNS, and rare diseases. 

Prior to launching her consultancy, she held roles at Pfizer, Epizyme, and Q32 Bio, leading toxicology programs from early discovery through IND/CTA submission. She is also an invited speaker, published author, and active contributor to professional societies including ACT, SOT, and CDISC.